Burning Rock Biotech Limited (BNR) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 16.50 and resistance around 17.53. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control. Pattern invalidation sits near 25.67, so a violation there would materially change the current setup narrative.

📊 Technical Summary

The latest close for Burning Rock Biotech Limited (BNR) came in at 17.00 (+4.68%). The chart is sitting below its 50-day average while still holding above the 200-day average, suggesting shorter-term weakness inside a still positive long-term backdrop. 20-day momentum is positive at +4.29%, with price remains inside its roughly 52-week range (2.32–41.06), while ATR14 volatility is elevated at roughly 10.61% of price. RSI(14) is 41.4, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. Near-term structure is defined by support at 16.50 and resistance at 17.53. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 39.77M · Net income: -78.16M. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more